(0.31%) 5 203.86 points
(0.47%) 39 242 points
(0.21%) 16 338 points
(0.32%) $79.24
(4.62%) $2.29
(0.77%) $2 340.10
(2.85%) $28.39
(0.70%) $991.45
(-0.21%) $0.928
(-0.22%) $10.87
(-0.13%) $0.799
(0.88%) $92.55
Quarter results today
(bmo 2024-05-09)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States...
Stats | |
---|---|
Dagens volum | 8 416.00 |
Gjennomsnittsvolum | 22 613.00 |
Markedsverdi | 35.37M |
EPS | $0 ( 2024-03-28 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.580 |
ATR14 | $0.0540 (1.89%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-03 | Milligan Sandra | Buy | 30 000 | EMPLOYEE STOCK OPTION (RIGHT TO BUY) |
2024-04-01 | Milligan Sandra | Buy | 0 | |
2024-02-15 | Sandford Nicole | Buy | 30 000 | Employee stock option (right to buy) |
2024-02-14 | Hombeck Torsten | Buy | 20 000 | Employee stock option (right to buy) |
2024-02-14 | Merchant Minh Hoang | Buy | 11 000 | Employee stock option (right to buy) |
INSIDER POWER |
---|
97.47 |
Last 89 transactions |
Buy: 4 309 531 | Sell: 195 424 |
Aspira Women's Health Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Aspira Women's Health Korrelasjon - Valuta/Råvare
Aspira Women's Health Økonomi
Annual | 2023 |
Omsetning: | $9.15M |
Bruttogevinst: | $5.26M (57.48 %) |
EPS: | $-1.810 |
FY | 2023 |
Omsetning: | $9.15M |
Bruttogevinst: | $5.26M (57.48 %) |
EPS: | $-1.810 |
FY | 2022 |
Omsetning: | $8.18M |
Bruttogevinst: | $4.32M (52.77 %) |
EPS: | $-41.66 |
FY | 2021 |
Omsetning: | $6.81M |
Bruttogevinst: | $3.06M (44.95 %) |
EPS: | $-0.280 |
Financial Reports:
No articles found.
Aspira Women's Health
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service for decentralized access of protein biomarker and hereditary genetic testing; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, its pipeline products include OVAWatch, EndoCheck, and OVAInherit. The company serves physicians, physician office laboratories, and national and regional laboratories. It has a collaborative research agreement with Baylor Genetics; an agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.